Biological Characterization of TAK-901, an Investigational, Novel, Multitargeted Aurora B Kinase InhibitorPamela Farrell, Ron de Jong, Lihong Shi et al.|Molecular Cancer Therapeutics|2013Cited by 46
Differential effect of cannabis use on opioid agonist treatment outcomes: Exploratory analyses from the OPTIMA studyLaurent Elkrief, Louis-Christophe Juteau, Bernard Le Foll et al.|Journal of Substance Use and Addiction Treatment|2023Cited by 9
Abstract C193: Biological evaluation of novel multi-targeted Aurora-B kinase inhibitor TAK-901 in xenograft modelsTakashi Satou, Ron de Jong, Takashi Hoshino et al.|Molecular Cancer Therapeutics|2009Cited by 0